Congenital and Perinatal Infections pp 271-288

Part of the Infectious Disease book series (ID)

Mycoplasma and Ureaplasma

  • Ken B. Waites


The concept that Mycoplasma hominis and Ureaplasma spp could be important pathogens that may affect pregnancy outcomes and the health of neonates was first given serious consideration in the 1960s and early 1970s when reports of postpartum endometritis with septicemia, chorioamnionitis, and low birth weight caused by these organisms began to appear and a treatment trial of pregnant women given tetracycline showed a significant beneficial effect on birth weight for their infants (1, 2, 3, 4). Since those days, a great many more case reports have been described, and numerous clinical studies have been performed in an attempt to clarify what roles, if any, these organisms play as agents responsible for invasive infections in neonates, premature labor, spontaneous abortion, stillbirth, and chronic lung disease of prematurity.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tully JG, Smith LG. Postpartum septicemia with Mycoplasma hominis. JAMA 1968;204:827–828.PubMedCrossRefGoogle Scholar
  2. 2.
    Shurin PA, Alpert S, Bernard Rosner BA, Driscoll SG, Lee YH. Chorioamnionitis and colonization of the newborn infant with genital mycoplasmas. N Engl J Med 1975;293:5–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Klein JO, Buckland D, Finland M. Colonization of newborn infants by mycoplasmas. N Engl J Med 1969;280:1025–1030.PubMedCrossRefGoogle Scholar
  4. 4.
    Elder HA, Santamarina BA, Smith S, Kass EH. The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. Am J Obstet Gynecol 1971;111:441–462.PubMedGoogle Scholar
  5. 5.
    Cassell GH, Waites KB, Crouse DT. Mycoplasmal infections. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant, 5th ed. Philadelphia: Saunders, 2001:733–767.Google Scholar
  6. 6.
    Taylor-Robinson D, Ainsworth JG, McCormack WM. Genital mycoplasmas. In: Holmes KK, Mardh PA, Sparling PF, et al., eds. Sexually Transmitted Diseases, 3rd ed. New York: McGraw Hill, 1999:533–548.Google Scholar
  7. 7.
    Ursi D, Ursi JP, Ieven M, Docx M, Van Reempts P, Pattyn SR. Congenital pneumonia due to Mycoplasma pneumoniae. Arch Dis Child Fetal Neonatal Ed 1995;72:F118–F120.PubMedCrossRefGoogle Scholar
  8. 8.
    Taylor-Robinson D. Mycoplasma genitalium—an up-date. Int J STD AIDS 2002;13:145–151.PubMedCrossRefGoogle Scholar
  9. 9.
    Blanchard A, Hamrick W, Duffy L, Baldus K, Cassell GH. Use of the polymerase chain reaction for detection of Mycoplasma fermentans and Mycoplasma genitalium in the urogenital tract and amniotic fluid. Clin Infect Dis 1993;17(Suppl 1):S272–S279.PubMedGoogle Scholar
  10. 10.
    Labbe AC, Frost E, Deslandes S, Mendonca AP, Alves AC, Pepin J. Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bissau. Sex Transm Infect 2002;78:289–291.PubMedCrossRefGoogle Scholar
  11. 11.
    Lu GC, Schwebke JR, Duffy LB, et al. Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2001;185:163–165.PubMedCrossRefGoogle Scholar
  12. 12.
    Kovachev E, Popova A, Protopopov F, Minkov R, Tsvetkova S. [Association between Mycoplasma genitalium and preterm labor]. Akush Ginekol (Sofia) 2002;41:26–29.Google Scholar
  13. 13.
    Luki N, Lebel P, Boucher M, Doray B, Turgeon J, Brousseau R. Comparison of polymerase chain reaction assay with culture for detection of genital mycoplasmas in perinatal infections. Eur J Clin Microbiol Infect Dis 1998;17:255–263.PubMedGoogle Scholar
  14. 14.
    Waites KB, Rikihisa Y, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology, 8th ed. Washington, DC: American Society for Microbiology, 2003:972–990.Google Scholar
  15. 15.
    Kim M, Kim G, Romero R, Shim SS, Kim EC, Yoon BH. Biovar diversity of Ureaplasma urealyticum in amniotic fluid: distribution, intrauterine inflammatory response and pregnancy outcomes. J Perinat Med 2003;31:146–152.PubMedCrossRefGoogle Scholar
  16. 16.
    Zheng X, Watson HL, Waites KB, Cassell GH. Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates. Infect Immunol 1992;60:3472–3474.Google Scholar
  17. 17.
    Abele-Horn M, Wolff C, Dressel P, Pfaff F, Zimmermann A. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease. J Clin Microbiol 1997;35:1199–1202.PubMedGoogle Scholar
  18. 18.
    Naessens A, Foulon W, Breynaert J, Lauwers S. Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications. J Clin Microbiol 1988;26:319–322.PubMedGoogle Scholar
  19. 19.
    Martinez MA, Ovalle A, Santa-Cruz A, Barrera B, Vidal R, Aguirre R. Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women. Scand J Infect Dis 2001;33:604–610.PubMedCrossRefGoogle Scholar
  20. 20.
    Domingues D, Tavira LT, Duarte A, Sanca A, Prieto E, Exposto F. Ureaplasma urealyticum biovar determination in women attending a family planning clinic in Guine-Bissau, using polymerase chain reaction of the multiple-banded antigen gene. J Clin Lab Anal 2002;16:71–75.PubMedCrossRefGoogle Scholar
  21. 21.
    Sanchez PJ. Perinatal transmission of Ureaplasma urealyticum: current concepts based on review of the literature. Clin Infect Dis 1993;17(Suppl 1):S107–S111.PubMedGoogle Scholar
  22. 22.
    Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16–20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983;10(4 Suppl):294–302.PubMedGoogle Scholar
  23. 23.
    Carey JC, Blackwelder WC, Nugent RP, et al. Antepartum cultures for Ureaplasma urealyticum are not useful in predicting pregnancy outcome. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1991;164:728–733.PubMedGoogle Scholar
  24. 24.
    Foulon W, Naessens A, Dewaele M, Lauwers S, Amy JJ. Chronic Ureaplasma urealyticum amnionitis associated with abruptio placentae. Obstet Gynecol 1986;68:280–282.PubMedGoogle Scholar
  25. 25.
    Gray DJ, Robinson HB, Malone J, Thomson RB Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992;12:111–117.PubMedCrossRefGoogle Scholar
  26. 26.
    Andrews WW, Shah SR, Goldenberg RL, Cliver SP, Hauth JC, Cassell GH. Association of post-cesarean delivery endometritis with colonization of the chorioamnion by Ureaplasma urealyticum. Obstet Gynecol 1995;85:509–514.PubMedCrossRefGoogle Scholar
  27. 27.
    Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002;8:3–13.PubMedCrossRefGoogle Scholar
  28. 28.
    Martius J, Eschenbach DA. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnonitis, and prematurity—a review. Arch Obstet Gynecol 1990;247:1–13.CrossRefGoogle Scholar
  29. 29.
    Taylor-Robinson D, Waites K, Cassell G. Genital mycoplasmas. In: Morse SA, Ballard RC, Holmes KK, Moreland AA, eds. Atlas of Sexually Transmitted Diseases and AIDS, 3rd ed. New York: Mosby, 2003:127–139.Google Scholar
  30. 30.
    Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737–1742.PubMedCrossRefGoogle Scholar
  31. 31.
    Donders GG, Van Bulck B, Caudron J, Londers L, Vereecken A, Spitz B. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol 2000;183:431–437.PubMedCrossRefGoogle Scholar
  32. 32.
    Madan E, Meyer MP, Amortegui AJ. Isolation of genital mycoplasmas and Chlamydia trachomatis in stillborn and neonatal autopsy material. Arch Pathol Lab Med 1988;112:749–751.PubMedGoogle Scholar
  33. 33.
    Kundsin RB, Driscoll SG, Monson RR, Yeh C, Biano SA, Cochran WD. Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality. N Engl J Med 1984;310:941–945.PubMedCrossRefGoogle Scholar
  34. 34.
    Quinn PA, Butany J, Chipman M, Taylor J, Hannah W. A prospective study of microbial infection in stillbirths and early neonatal death. Am J Obstet Gynecol 1985;151:238–249.PubMedGoogle Scholar
  35. 35.
    Cassell GH, Waites KB, Crouse DT, et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet 1988;2:240–245.PubMedCrossRefGoogle Scholar
  36. 36.
    Wang EE, Frayha H, Watts J, et al. Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J 1988;7:547–551.PubMedGoogle Scholar
  37. 37.
    Sanchez PJ, Regan JA. Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants. Pediatr Infect Dis J 1988;7:542–546.PubMedGoogle Scholar
  38. 38.
    Crouse DT, Odrezin GT, Cutter GR, et al. Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates. Clin Infect Dis 1993;17(Suppl 1):S122–S130.PubMedGoogle Scholar
  39. 39.
    Payne NR, Steinberg SS, Ackerman P, et al. New prospective studies of the association of Ureaplasma urealyticum colonization and chronic lung disease. Clin Infect Dis 1993;17(Suppl 1):S117–S121.PubMedGoogle Scholar
  40. 40.
    Wang EE, Ohlsson A, Kellner JD. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis. J Pediatr 1995;127:640–644.PubMedCrossRefGoogle Scholar
  41. 41.
    Ollikainen J, Korppi M, Heiskanen-Kosma T, Heinonen K. Chronic lung disease of the newborn is not associated with Ureaplasma urealyticum. Pediatr Pulmonol 2001;32:303–307.PubMedCrossRefGoogle Scholar
  42. 42.
    Heggie AD, Bar-Shain D, Boxerbaum B, Fanaroff AA, O’Riordan MA, Robertson JA. Identification and quantification of ureaplasmas colonizing the respiratory tract and assessment of their role in the development of chronic lung disease in preterm infants. Pediatr Infect Dis J 2001;20:854–859.PubMedCrossRefGoogle Scholar
  43. 43.
    Smyth AR, Shaw NJ, Pratt BC, Weindling AM. Ureaplasma urealyticum and chronic lung disease. Eur J Pediatr 1993;152:931–932.PubMedCrossRefGoogle Scholar
  44. 44.
    Saxen H, Hakkarainen K, Pohjavuori M, Miettinen A. Chronic lung disease of preterm infants in Finland is not associated with Ureaplasma urealyticum colonization. Acta Paediatr 1993;82:198–201.PubMedGoogle Scholar
  45. 45.
    Berger A, Witt A, Haiden N, Kretzer V, Heinze G, Kohlhauser C. Microbial invasion of the amniotic cavity at birth is associated with adverse short-term outcome of preterm infants. J Perinat Med 2003;31:115–121.PubMedCrossRefGoogle Scholar
  46. 46.
    Galetto Lacour A, Zamora S, Bertrand R, et al. [Colonization by Ureaplasma urealyticum and chronic lung disease in premature newborn infants under 32 weeks of gestation]. Arch Pediatr 2001;8:39–46.CrossRefGoogle Scholar
  47. 47.
    Waites KB, Katz B, Schelonka R. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbial Rev 2005. In press.Google Scholar
  48. 48.
    Ollikainen J. Perinatal Ureaplasma urealyticum infection increases the need for hospital treatment during the first year of life in preterm infants. Pediatr Pulmonol 2000;30:402–405.PubMedCrossRefGoogle Scholar
  49. 49.
    Rudd PT, Cassell GH, Waites KB, Davis JK, Duffy LB. Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility. Infect Immunol 1989;57:918–925.Google Scholar
  50. 50.
    Viscardi RM, Kaplan J, Lovchik JC, et al. Characterization of a murine model of Ureaplasma urealyticum pneumonia. Infect Immunol 2002;70:5721–5729.CrossRefGoogle Scholar
  51. 51.
    Crouse DT, Cassell GH, Waites KB, Foster JM, Cassady G. Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice. Infect Immunol 1990;58:3487–3493.Google Scholar
  52. 52.
    Waites KB, Sims PJ, Crouse DT, et al. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J 1994;13:287–293.PubMedCrossRefGoogle Scholar
  53. 53.
    Waites KB, Duffy LB, Crouse DT, et al. Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J 1990;9:241–245.PubMedGoogle Scholar
  54. 54.
    Waites KB, Rudd PT, Crouse DT, et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet 1988;1:17–21.PubMedCrossRefGoogle Scholar
  55. 55.
    Ollikainen J, Hiekkaniemi H, Korppi M, Katila ML, Heinonen K. Ureaplasma urealyticum cultured from brain tissue of preterm twins who died of intraventricular hemorrhage. Scand J Infect Dis 1993;25:529–531.PubMedGoogle Scholar
  56. 56.
    Rao RP, Ghanayem NS, Kaufman BA, Kehl KS, Gregg DC, Chusid MJ. Mycoplasma hominis and Ureaplasma species brain abscess in a neonate. Pediatr Infect Dis J 2002;21:1083–1085.PubMedCrossRefGoogle Scholar
  57. 57.
    Miller TC, Sudhaker IB, Albers WH. Massive pericardial effusion due to Mycoplasma hominis in a newborn. Am J Dis Child 1982;136:271–272.PubMedGoogle Scholar
  58. 58.
    Glaser JB, Engelberg M, Hammerschlag M. Scalp abscess associated with Mycoplasma hominis infection complicating intrapartum monitoring. Pediatr Infect Dis 1983;2:468–470.PubMedGoogle Scholar
  59. 59.
    Hamrick HJ, Mangum ME, Katz VL. Ureaplasma urealyticum abscess at site of an internal fetal heart rate monitor. Pediatr Infect Dis J 1993;12:410–411.PubMedCrossRefGoogle Scholar
  60. 60.
    Waites KB, Crouse DT, Philips JB, 3rd, Canupp KC, Cassell GH. Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn. Pediatrics 1989;83:79–85.PubMedGoogle Scholar
  61. 61.
    Brus F, van Waarde WM, Schoots C, Oetomo SB. Fatal ureaplasmal pneumonia and sepsis in a newborn infant. Eur J Pediatr 1991;150:782–783.PubMedCrossRefGoogle Scholar
  62. 62.
    Waites KB, Bebear CM, Robertson JA, Talkington DF, Kenny GE, eds. Cumitech 34, Laboratory Diagnosis of Mycoplasmal Infections. Washington, DC: American Society for Microbiology, 2001.Google Scholar
  63. 63.
    Waites KB, Canupp KC. Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures. J Clin Microbiol 2001;39:4328–4331.PubMedCrossRefGoogle Scholar
  64. 64.
    Waites KB, Talkington DF, Bebear CM. Mycoplasmas. In: Truant AL, ed. Manual of Commercial Methods in Clinical Microbiology. Washington, DC: American Society for Microbiology, 2002:201–224.Google Scholar
  65. 65.
    Quinn PA. Evidence of an immune response to Ureaplasma urealyticum in perinatal morbidity and mortality. Pediatr Infect Dis 1986;5(6 Suppl):S282–S287.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Ken B. Waites
    • 1
  1. 1.Division of Laboratory Medicine, Department of PathologyUniversity of Alabama at BirminghamBirminghamAL

Personalised recommendations